Gilead Sciences, Inc. (LON:0QYQ)
London · Delayed Price · Currency is GBP · Price in USD 116.73
-0.67 (-0.57%)
At close: Oct 9, 2025
Gilead Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| 28,718 | 28,610 | 26,934 | 26,982 | 27,008 | 24,355 | Upgrade | |
Revenue Growth (YoY) | 3.96% | 6.22% | -0.18% | -0.10% | 10.89% | 10.11% | Upgrade |
Cost of Revenue | 6,196 | 6,251 | 6,498 | 5,657 | 6,601 | 4,572 | Upgrade |
Gross Profit | 22,522 | 22,359 | 20,436 | 21,325 | 20,407 | 19,783 | Upgrade |
Selling, General & Admin | 5,963 | 6,091 | 6,090 | 5,673 | 5,246 | 5,151 | Upgrade |
Research & Development | 6,714 | 14,750 | 6,923 | 8,621 | 5,540 | 10,895 | Upgrade |
Operating Income | 8,051 | 1,662 | 7,605 | 7,330 | 9,918 | 4,071 | Upgrade |
Interest Expense | 1,001 | 977 | 944 | 935 | -1,001 | -984 | Upgrade |
Other Non-Operating Income (Expense) | 151 | 6 | 198 | -581 | -639 | -1,418 | Upgrade |
Total Non-Operating Income (Expense) | 1,152 | 983 | 1,142 | 354 | -1,640 | -2,402 | Upgrade |
Pretax Income | 7,201 | 690 | 6,859 | 5,814 | 8,278 | 1,669 | Upgrade |
Provision for Income Taxes | 890 | 211 | 1,247 | 1,248 | -2,077 | -1,580 | Upgrade |
Net Income | 6,311 | 480 | 5,665 | 4,592 | 6,225 | 123 | Upgrade |
Minority Interest in Earnings | - | - | -52 | -26 | 24 | 34 | Upgrade |
Net Income to Common | 6,311 | 480 | 5,665 | 4,592 | 6,225 | 123 | Upgrade |
Net Income Growth | 499.34% | -91.53% | 23.37% | -26.23% | 4960.98% | -97.72% | Upgrade |
Shares Outstanding (Basic) | 1,246 | 1,247 | 1,248 | 1,255 | 1,256 | 1,257 | Upgrade |
Shares Outstanding (Diluted) | 1,262 | 1,255 | 1,258 | 1,262 | 1,262 | 1,263 | Upgrade |
Shares Change (YoY) | 0.74% | -0.24% | -0.32% | - | -0.08% | -1.10% | Upgrade |
EPS (Basic) | 5.05 | 0.38 | 4.54 | 3.66 | 4.96 | 0.10 | Upgrade |
EPS (Diluted) | 5.02 | 0.38 | 4.50 | 3.64 | 4.93 | 0.10 | Upgrade |
EPS Growth | 519.75% | -91.56% | 23.63% | -26.17% | 4830.00% | -97.63% | Upgrade |
Free Cash Flow | 7,431 | 10,305 | 7,420 | 8,344 | 10,805 | 7,696 | Upgrade |
Free Cash Flow Growth | -27.89% | 38.88% | -11.07% | -22.78% | 40.40% | -7.49% | Upgrade |
Free Cash Flow Per Share | 5.89 | 8.21 | 5.90 | 6.61 | 8.56 | 6.09 | Upgrade |
Dividends Per Share | 3.120 | 3.080 | 3.000 | 2.920 | 2.840 | 2.720 | Upgrade |
Dividend Growth | 1.30% | 2.67% | 2.74% | 2.82% | 4.41% | 7.94% | Upgrade |
Gross Margin | 78.42% | 78.15% | 75.87% | 79.03% | 75.56% | 81.23% | Upgrade |
Operating Margin | 28.03% | 5.81% | 28.24% | 27.17% | 36.72% | 16.72% | Upgrade |
Profit Margin | 21.98% | 1.68% | 20.84% | 16.92% | 22.96% | 0.37% | Upgrade |
FCF Margin | 25.88% | 36.02% | 27.55% | 30.92% | 40.01% | 31.60% | Upgrade |
EBITDA | 10,821 | 4,429 | 10,298 | 9,433 | 11,968 | 5,551 | Upgrade |
EBITDA Margin | 37.68% | 15.48% | 38.23% | 34.96% | 44.31% | 22.79% | Upgrade |
EBIT | 8,051 | 1,662 | 7,605 | 7,330 | 9,918 | 4,071 | Upgrade |
EBIT Margin | 28.03% | 5.81% | 28.24% | 27.17% | 36.72% | 16.72% | Upgrade |
Effective Tax Rate | 12.36% | 30.58% | 18.18% | 21.47% | -25.09% | -94.67% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.